This site is intended for Healthcare Professionals only.

Contaminated eye gels from India led to one death in the UK


Share post:

Carbomer-containing eye gels that are currently being sold in the UK are safe to use and free of contamination, says MHRA

The outbreak of Burkholderia cepacia complex (Bcc) in the UK, which is associated with contaminated eye gels imported from India, has led to the death of one person, and many others falling ill, according to a government report.

Bcc is a group of antibiotic-resistant bacteria that are widely found within the environment. Although it rarely causes infection, it can result in severe ones in individuals with compromised immune systems and those living with cystic fibrosis, the UK Health Security Agency (UKHSA) said.

Between January 2023 and February 2024, there were 52 confirmed and six probable cases across the UK linked to the bacteria outbreak, as revealed in the Health Protection Report published by UKHSA.

Forty-one of these cases were hospital inpatients, 38 of which were in critical-care settings.

Twenty-five cases were considered to have “clinically significant infections attributable to Bcc”, out of which 11 had eye infections, nine had respiratory infections and four had bacteremia (bacteria entering the bloodstream).

Two individuals with cystic fibrosis (CF) were infected, and while one was treated, the other died, with the report indicating Bcc infection to have “contributed to the death.”

Following a thorough investigation last year, three carbomer-containing lubricating eye drops – AaCarb, Aacomer and Purpotics eye gel – were identified as the source of this superbug outbreak. These products were produced by a single manufacturer based in India, Indiana Ophthalmics,  and are used to treat dry eyes.

Subsequently, the manufacturer withheld the distribution and recalled the affected eye gels from the market, issuing a Field Safety Notice on 22 November 2023.

The Medicines and Healthcare products Regulatory Agency (MHRA) also issued a Device Safety Information and a National Patient Safety Alert, advising health professionals to avoid supplying carbomer-containing eye products to certain patients.

No need to avoid using eye gels 

The UK’s medicines watchdog said that it has now received “sufficient assurance from manufacturers and suppliers to conclude that products available on the UK market are safe to use and free of contamination.”

“As of 21 March 2024, UKHSA, MHRA and the Incident Management Team are satisfied that the risk associated with this outbreak has reduced such that there is no longer need to avoid use of carbomer-containing lubricating eye products.

“Therefore, the recommendation to avoid use of all carbomer-containing eye products in individuals with cystic fibrosis, patients being cared for in critical care settings, the severely immunocompromised and patients awaiting lung transplantation has been stepped down,” the report said.

However, UKHSA said it will continue to “follow up new cases and keep vigilance for emergent clusters of Burkholderia cepacia complex.”




Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Head lice cases on the rise across the UK, warns Superdrug

If lotions or sprays prove ineffective, consulting a pharmacist about alternative head lice treatments is recommended Parents are...

Gender identity services: GPhC publishes new resource for pharmacy professionals

The regulatory body sets out questions that pharmacy professionals should ask themselves when providing gender identity care  The General...

NHS patient safety initiative: 143 hospitals across England to roll out Martha’s Rule

This programme has the opportunity to truly transform “patient care and safety” NHS England has confirmed the initial sites...

Why You Shouldn’t Delay in Filing a Medical Malpractice Claim

When faced with the unfortunate situation of medical malpractice, it’s understandable that you may feel overwhelmed and uncertain...